[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367095-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367095-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","association-of-blood-group-types-and-clinico-pathological-features-of-gynecological-cancers-gcs","Association of blood group types and clinico-pathological features of gynecological cancers (GCs)","","Gynecological cancers affect the female reproductive system and include cervical, endometrial, and ovarian malignancies, with susceptibility influenced by multiple risk factors. This retrospective cross-sectional study analyzed demographic and clinical data for patients aged over 18 with recorded blood group and confirmed FIGO-based histological or cytological diagnoses. Among 543 women, O+ was most prevalent, and comorbid hypertension, diabetes, and dyslipidemia were common. Significant associations were observed between ABO blood group variants and cancer histology, recurrence, and survival-related outcomes across several gynecologic cancer groups.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/association-of-blood-group-types-and-clinico-pathological-features-of-gynecological-cancers-gcs/367095/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/association-of-blood-group-types-and-clinico-pathological-features-of-gynecological-cancers-gcs/367095.png","ImageObject",300,407,{"name":42,"@type":43},"Olivia Brown","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",15,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the study’s main objective regarding ABO blood groups and gynecological cancers?","Question",{"text":63,"@type":64},"To evaluate demographics of gynecological cancer patients and investigate the relationship between the ABO blood group system and the risk of developing these cancers in the study population.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What study design and time range were used?",{"text":68,"@type":64},"A retrospective cross-sectional study was conducted between 2016 and 2023, including patients with documented blood group and confirmed FIGO-guideline histological or cytological diagnoses.",{"name":70,"@type":61,"acceptedAnswer":71},"What key findings were reported about blood group frequencies and associations?",{"text":72,"@type":64},"O+ was the most prevalent blood group among cases. The study reported significant associations between ABO blood groups and specific histology types and, in some cancer groups, recurrence and survival-related outcomes.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367095,1790817266,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Aga et al. BMC Cancer (2025) 25:137  \n[https://doi.org/10.1186/s12885-025-13527-z](https://doi.org/10.1186/s12885-025-13527-z)  \nBMC Cancer  \n RESEARCH Open Access  \nAssociation of blood group types and clinico-pathological features of gynecological cancers (GCs)  \nSyed Sameer Aga1,2*, Muhammad Anwar Khan2, Mubarak Al Mansour3, Rana Mohammed Hasosah 1, Lulu Abdullah Alsubaie1, Dala Ahmad Alfaify1, Malak Badr Alansari1, Shahad Obaidallah Almutairi1 and Saniya Nissar4  \nAbstract  \nBackground Gynecological cancers (GCs) affect the reproductive system of females, and are of multiple types depending on the affected organ most common of which are cervical, endometrial, ovarian cancers. Among different risk factors for GCs, ABO blood group system is considered as one of the pivotal contributing factors for increased susceptibility of GCs. The aim of our study was to report on the demographics of GC patients and to investigate the relationship between the ABO blood group system and the risk of acquiring GC in our population.  \nMethods The current retrospective cross-sectional study was carried out between the years of 2016 and 2023. The sample included all the patients having age > 18 with a record of blood group and confirmed histological or cytological diagnosis as per International Federation of Gynecology and Obstetrics (FIGO) guidelines. A comprehensive review of the charts was conducted to gather data including demographics, tumor characteristics, comorbidities, adverse effects, and treatment methods.  \nResults A total of 543 female patients were included in the study. The mean age of patients was 61.6. The three most common BG in our GC cases were as O + (43 . 8%), followed by A + (26%), and B + (15 . 5%) . Among comorbidities, hypertension (HTN), diabetes mellitus (DM), dyslipidemia were the top three affecting GC patients. A significant association (p \u003C 0. 05) between ABO BG and serous histology in endometrial cancer was found. ABO blood group and fallopian cancer showed a significant relationship between serous histology and B blood group (p \u003C 0. 05) . For ovarian cancer a significant association between AB blood group and recurrence rates were found (p \u003C 0. 05) . In case of the patient dependent GCs, a significant association between ovarian cancers and recurrence, fallopian tube cancers and adverse events and survival status, vaginal/vulval cancers and TNM stage and mixed GCs and tumor type (carcinoma) was observed (P \u003C 0. 05) . Furthermore, multinomial analysis between various confounding factors and GCs revealed that the risk of Cervical, Endometrial and Ovarian cancers to be significant for Type B BG (P \u003C 0. 05) .  \nConclusion Our study found that O + BG was the most prevalent among our population. Furthermore, there  \nwas a significant association between BG B and endometrial and serous histology in fallopian tube and between BG AB and ovarian malignancies, respectively. Additionally, multinomial analysis revealed higher risk of Cervical, Endometrial and Ovarian cancers for Type B BG (P \u003C 0. 05) .  \n*Correspondence: Syed Sameer Aga[agas@ksau-hs.edu.sa](agas@ksau-hs.edu.sa)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons lic","cbCaioWQ3EX8zuDW","https://ap.wps.com/l/cbCaioWQ3EX8zuDW","pdf",1072006,21,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Keywords\n# Introduction","[{\"question\":\"What is the study’s main objective regarding ABO blood groups and gynecological cancers?\",\"answer\":\"To evaluate demographics of gynecological cancer patients and investigate the relationship between the ABO blood group system and the risk of developing these cancers in the study population.\"},{\"question\":\"What study design and time range were used?\",\"answer\":\"A retrospective cross-sectional study was conducted between 2016 and 2023, including patients with documented blood group and confirmed FIGO-guideline histological or cytological diagnoses.\"},{\"question\":\"What key findings were reported about blood group frequencies and associations?\",\"answer\":\"O+ was the most prevalent blood group among cases. The study reported significant associations between ABO blood groups and specific histology types and, in some cancer groups, recurrence and survival-related outcomes.\"}]","Association of blood group types and clinico-pathological features of gynecological cancers (GCs) | PDF",1790169255,53,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/999c9748dfa5a8a814482e470cc6b101.webp",983,1305,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f02bd4278c971f5e0b415c8c78af77fc.webp",982,1304,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a0c21f96b8598a7088ed458af61720cd.webp",981,1303,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7099b632c210d2f7edeb531a5dfc3ff6.webp",980,1301]